Mode
Text Size
Log in / Sign up
N/A N=11 Treatment

Subject´s Preference Regarding Hearing Performance and Functionality Using a New Sound Processor

Deafness; Sensoneural Single Sided · Conductive Hearing Loss · Mixed Hearing Loss

Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Feb 2020
Primary outcome: Primary: Abbreviated Profile of Hearing Aid Benefit (APHAB) — 6.3; 7.0; 5.6; 3.5 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Investigational device - Sound Processor (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Cochlear
Primary completion
Apr 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Abbreviated Profile of Hearing Aid Benefit (APHAB)
6.3; 7.0; 5.6; 3.5; 6.3
PRIMARY
Speech, Spatial, and Qualities of Hearing Scale (SSQ)
1.0; 0.061; 0.96; 0.68
PRIMARY
Self-reported Assessment Regarding Satisfaction and Usability (QUEST Version 2)
0; 0; 3; 4; 4; 0
PRIMARY
Audiometric Thresholds in Freefield, Pure Tone Average 4 (PTA4)
-2.5
PRIMARY
Audiometric Thresholds in Freefield, Individual Frequencies
-2.3; -3.6; -6.4; -3.6; -3.6; -1.2
PRIMARY
Adaptive Speech Recognition in Noise Ratio
-1.3; -1.2
PRIMARY
Speech in Quiet
82.5; 83.3; 93.7; 96.9; 94.4; 96.9
PRIMARY
To Compare the Subject´s Overall Preference Regarding the Investigational Device and the Precursor Sound Processor
0; 0; 11
PRIMARY
To Assess the Subject's Experience Regarding Comfort
84.9; 87.5
PRIMARY
To Assess the Subject's Experience Regarding Usage; Magnet Choice
1; 3; 3; 4
PRIMARY
To Assess the Subject's Experience Regarding Usage; Battery Life Time
2; 1; 2; 3; 1; 1
PRIMARY
To Assess the Subject's Experience Regarding Usage; Softwear Pad
2; 9
PRIMARY
To Assess the Subject's Experience Regarding Usage; Safety Line
9; 2
PRIMARY
To Assess the Subject's Experience Regarding Usage; Wireless Accessories
11; 0

Summary

The aim of this clinical investigation is to investigate the subject´s overall preference, hearing performance and self-reported assessments with the Investigational device and its precursor Sound Processor (Comparator) after 6 weeks in subjects with conductive/mixed hearing loss or Single Sided Deafness, (SSD).

Eligibility Criteria

Inclusion Criteria

  • Completed clinical investigation CBAS5539, and an active user of the Osia System.
  • Signed Informed consent.
  • Subject with conductive or mixed hearing loss in the implanted ear. Bone conduction thresholds with pure tone average (PTA4; mean of 0.5, 1, 2 and 4 kHz) of ≤ 55 dB HL.

OR subject with single-sided sensorineural deafness. Air conduction thresholds with a pure tone average PTA4 of ≤ 20 dB (decibel) HL (Hearing Level) (mean of 0.5, 1, 2 and 3 kHz) in the good ear.

  • Optimally fitted with Osia Sound processor, according to subject's experience prior to inclusion.

Exclusion Criteria

  • Any ongoing soft tissue complication that could significantly affect the use of the Osia 2 Sound Processor during the 6 weeks period
  • Use of ototoxic drugs that could be harmful to the hearing, as judged by the investigator
  • Unable to follow investigational procedures and instructions, e.g. inability to complete quality of life scales or audiological testing as described in the Clinical Investigation Plan (CIP).
  • Participation in another clinical investigation with pharmaceutical and/or device.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03848910). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search